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Background: Saffron extract, a natural product, has been shown to induce apoptosis in several tumor cell lines.
Nevertheless, the p53-dependency of saffron’s mechanism of action in colon cancer remains unexplored.
Material and methods: In order to examine saffron’s anti-proliferative and pro-apoptotic effects in colorectal
cancer cells, we treated two p53 isogenic HCT116 cell lines (HCT wildtype and HCT p53−/−) with different doses of
the drug and analyzed cell proliferation and apoptosis in a time-dependent manner. MTT viability and crystal
violet assays were performed in order to determine the effective dose of saffron on both cell lines. The cell cycle
progress was examined by Flow cytometric analysis. Apoptosis was assessed using Annexin-PI-staining and
Western Blotting for caspase 3 and PARP cleavage. Autophagy was determined by Western Blotting of the light
chain 3 (LC3)-II and Beclin 1 proteins. The protein content of phospho-H2AX (γH2AX), a sensor of DNA double
strand breaks, was also analyzed by Western Blotting.
Results: Saffron extract induced a p53-dependent pattern of cell cycle distribution with a full G2/M stop in HCT116
p53 wildtype cells. However, it induced a remarkable delay in S/G2 phase transit with entry into mitosis in
HCT116 p53 −/− cells. The apoptotic Pre-G1 cell fraction as well as Annexin V staining and caspase 3 cleavage
showed a more pronounced apoptosis induction in HCT116 p53 wildtype cells. Obviously, the significantly higher
DNA-damage, reflected by ɣH2AX protein levels in cells lacking p53, was coped by up-regulation of autophagy.
The saffron-induced LC3-II protein level was a remarkable indication of the accumulation of autophagosomes,
a response to the cellular stress condition of drug treatment.
Conclusions: This is the first study showing the effect of saffron in HCT116 colorectal cancer cells with different
p53 status. Saffron induced DNA-damage and apoptosis in both cell lines. However, autophagy has delayed
the induction of apoptosis in HCT116 p53 −/− cells. Considering the fact that most tumors show a functional p53
inactivation, further research is needed to elucidate the long-term effects of saffron in p53 −/− tumors.Background
Colorectal cancer is one of the most common malignan-
cies in the world with approximately one million new
cases diagnosed every year [1]. The high incidence of the
disease and its associated morbidity and mortality has
brought colorectal cancer to the center of cancer research,
namely its aetiology, diagnosis and treatment. In the last
few decades, the acquired knowledge of the molecular* Correspondence: regine.schneider-stock@uk-erlangen.de
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reproduction in any medium, provided the orbiology of the disease and the development of new thera-
peutic strategies has been steadily increasing [2].
Natural products encompass three main categories of
compounds, phenylpropanoids, isoprenoids, and alka-
loids, which are widely distributed in plant foods and
medicinal herbs [3-5]. This large array of molecules is
crucial to human nutrition and health. Plant-derived
foodstuffs and beverages also constitute the so-called
functional foods and beverages, which include mainly
fruits, vegetables, herbs and spices [6]. Saffron, the dried
styles (stigmata) of Crocus sativus L. flowers, is widely
known as a spice and its uses in traditional medicine are
well established and date back nearly 3000 years, span-
ning many continents, civilizations, and cultures [7,8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and flavor and is cultivated in various parts of the world,
particularly in Iran and Spain [9,10]. Cancer chemopro-
tection is based on the use of exogenous phytochemicals
to enhance endogenous mechanisms against various
stages of cancer development. There has been a great
deal of interest in exploring the chemopreventive prop-
erties of herbs and plants. For instance, saffron extracts
have the potential to make a major contribution to
effective chemopreventive therapy [11].
Studies in animal models and with cultured human
malignant cell lines have demonstrated anti-tumor and
anti-cancer activities of saffron [12-17]. Different hy-
potheses for anti-carcinogenic and anti-tumor effects of
saffron and its ingredients have been proposed, includ-
ing (a) inhibition of synthesis of DNA and RNA, but not
protein [14], (b) ability to scavenge free radicals [18,19]
(c) involvement in the metabolic conversion of carote-
noids to retinoids [20], (d) mediation of interactions of
carotenoids with topoisomerase II, an enzyme involved
in cellular DNA–protein interaction [14], (e) promotion
of interactions mediated via lectins [21].
Most recently, we have shown pro-apoptotic and anti-
inflammatory effects of saffron extract against hepatocel-
lular carcinoma both in vitro and in vivo [11]. However,
the role of the tumor suppressor p53 in saffron-induced
programmed cell death has yet to be adequately
explored in colorectal cancer. Apoptosis is a gene regu-
lated phenomenon that is important both in physio-
logical and pathological conditions. The regulatory
mechanisms of apoptosis include, but are not limited to,
caspases and bcl-2 family proteins [22,23]. Since more
than 50% of colorectal carcinomas are characterized by a
loss of p53 function, here we will analyze the anti-
proliferative and pro-apoptotic effects of saffron in HCT
colon cancer cell lines with different p53 status.
Methods
Plant material and preparation
Stigmata of pure saffron were obtained from the Gol-
peech Saffron (www.golpeechsaffron.com, Register No.:
82558, Mashad, Iran) and voucher sample was preserved
for reference in the herbarium of UAEU. Five hundred
grams of the stigma materials were extracted at UAEU
with 80% (v/v) aqueous ethanol and the mixture was
macerated for five days at 4°C. The resulting mixture
was then filtered dried under reduced pressure in a ro-
tary evaporator at 40°C to give water and ethanol crude
extracts.
Cell culture and treatment
Human colon cancer HCT116 cell lines (HCT wildtype
and HCT p53−/−), obtained from ATCC, Manassas, VA,
were maintained in RPMI and DMEM, respectively, andsupplemented with 10% fetal bovine serum, penicillin
(100 U/ml), and streptomycin (100 μg/ml) inside a hu-
midified incubator with 5% CO2 and 95% room air. Cells
were subcultured every 4–7 days with trypsin/EDTA
(1:250) (PAA Laboratory, Germany). Cells were treated
with several concentrations of saffron extract for several
time points.
MTT cell proliferation assay
The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), a yellow tetrazole) proliferation assay
was utilized in HCT116 cell lines (HCT wildtype and
HCT p53−/−) to assess the dose-dependent effect of saf-
fron extract on cell proliferation. Cells (104) were plated
and grown in 200 μl of growth medium in 96-well micro-
titer plates. After an overnight attachment period, cells
were treated with varying concentrations of saffron
extract (0.25, 0.5, 1, 2, 3, 4, 5 mg/ml) prepared from a
100 mg/ml stock solution dissolved in water for 24 and
48 h. All studies were performed in triplicates and
repeated three times independently. Cell growth was
quantified by the ability of living cells to reduce the
yellow dye, MTT, to a purple formazan product. Cells
were incubated with MTT (Sigma-Aldrich, Steinheim,
Germany) at 37°C in a humidified 5% CO2 atmosphere
for 2 h. The MTT formazan product was then dissolved
in DMSO, and absorbance was measured at 570 nm in
a microplate reader.
Crystal violet assay
As a second method for determining the cytotoxicity of
saffron on HCT116 cells we used the crystal violet assay.
Upon solubilization, Cells (7.5 × 103) were seeded and
grown in 200 μl of growth medium in 96-well microtiter
plates. They were allowed to attach overnight before
saffron treatment as described for the MTT assay. After
washing with PBS the cells were incubated and were
slightly shaked at RT with 50 μl staining solution (0.5%
crystal violet, 20% methanol) which stains DNA. The
plate was washed 2 times with dH2O and dried com-
pletely. The uptaken crystal violet was solubilized by
addition of 200 μl of methanol and 15 min incubation
on a shaker. Finally, the amount of dye taken up by the
monolayer was quantified by measuring the absorbance
at 570 nm in a microplate reader. All studies were
performed in triplicates and repeated three times
independently.
Flow cytometric analysis of DNA content
One day before treatment, cells were seeded at a density
of 1.2 × 106 cells per well of a 6-well plate. After the indi-
cated times, the cells were harvested by trypsin release,
washed twice with phosphate buffered saline (PBS)
resuspended in 0.5 ml icecold PBS and fixed over night
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DNA fragments were extracted by 10 min incubation
with extraction buffer (9 parts 50 mM Na2HPO4, 1 part
25 mM citric acid and 0.1% triton x-100; pH 7.8). After
centrifugation the cells were resuspended and incubated
in the dark at RT in 0.4 ml staining buffer (10 mM
PIPES, 100 mM NaCl, 2 mM MgCl2, 0.1% triton x-100;
pH 6.8) with the addition of 250 μg RNase and propi-
dium iodide (50 μg/ml final concentration). Distribution
of cell cycle phases with different DNA contents
was determined using a flow cytometer FACS CantoII
(Becton-Dickinson, CA, USA). Sub G1 cells in flow cyto-
metric histograms were considered apoptotic cells. Ana-
lysis of cell cycle distribution and the percentage of cells
in the G1, S, and G2/M phases of the cell cycle were
determined using the cell cycle platform of the FlowJo
software with the Watson pragmatic model (Tree Star,
Ashland OR, USA).
Quantification of Apoptosis by AnnexinV-PI staining
To detect apoptosis, the AnnexinV-FLUOS kit (Roche
Diagnostics, USA) was used. Cells were treated for 24
and 48 h with saffron extract. After washing twice in
PBS, 1 × 106 cells were stained with 100 μl annexin V
staining solution, consisting of 20 μl FITC-conjugated
annexin V reagent (20 μg/ml), 20 μl isotonic propidium
iodide (50 μg/ml), and 1000 μl of 1 M/L HEPES buffer,
for 15 minutes at room temperature. Cells were analyzed
on a flow cytometer FACS CantoII (Becton-Dickinson,
CA, USA) using a 488 nm excitation and 530/30 nm
band pass filter for fluorescein detection and a long pass
filter 2P670 nm for propidium iodide detection after
electronic compensation. Since positive annexin V stain-
ing indicates apoptotic and necrotic cells, propidium
iodide-positive cells were used to measure late apoptotic
cells and necrotic cells whereas annexin V-positive and
propidium iodide-negative cells were counted as early
apoptotic cells.
Western Blotting
Whole cell lysates were prepared from both HCT116 cell
lines tumor cells. Protein concentration of lysates was
determined with Bio-Rad Dc Protein Assay (BioRad
Laboratories, Hercules, CA, USA), and 30 μg proteins were
loaded onto 12% SDS-polyacrylamide gel electrophoresis
(voltage: 30 mA, running time 1.5-2 h). Gels were trans-
ferred to nitrocellulose membranes before immunodetec-
tion processing with antibodies against phospho-H2AX
(Millipore), caspase 3, phospho-H3, PARP (all 3 Cell Sig-
naling Technology Inc., MA, USA), LC3 (Nanotools,
Germany), H3 (Actife Motif, CA, USA), cyclin B1 (Santa
Cruz, CA, USA) and with secondary antibodies (anti-
mouse or anti-rabbit IgG peroxidase conjugated; Pierce,
Rockford, IL, USA). Bound antibodies were detected byincubating the blots in West Pico chemiluminescent
substrate (Pierce, Rockford, IL, USA). The level of immu-
noreactivity was measured as peak intensity using an
image capture and analysis system (GeneGnome, Syngene,
UK). Hybridization with anti-GAPDH was used to
control equal loading and protein quality.
Statistical analysis
Data were analyzed using the Student t-test to calculate
the significance values; a probability value (p) <0.05 was
considered statistically significant.
Results
Saffron has an anti-proliferative effect in p53 isogenic
HCT116 cell lines
To determine the anti-viability effect of saffron, both cell
lines were treated with various concentrations of saffron
for 24 and 48 h. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a yellow tetrazole) is reduced
to purple formazan in living cells and using the MTT test
we can measure the viability and proliferation of cells after
drug administration. Saffron reduced the proliferation of
HCT116 cells in a time- and concentration-dependent
manner. The most remarkable effects were observed at
concentrations between 2 and 4 mg/ml (Figure 1A and B).
The mitochondrial function of HCT116 p53−/− cells was
more efficiently diminished by the drug at doses between 1
and 4 mg/ml.
Crystal violet staining was used to determine the num-
ber of viable cells after drug exposure. It confirmed that
saffron significantly decreased the viability of both cell
lines (p < 0.05) at 3 mg/ml (Figure 1C and D). HCT116
p53 wildtype cells died significantly more than HCT116
p53−/− cells with 3 and 5 mg/ml at both time points,
24 h (26% versus 40% respectively) and at 48 h (14% ver-
sus 28%, respectively) (p < 0.05).
Saffron induces a p53-dependent cell cycle arrest in
HCT116 cells
To examine the effect of saffron on cell cycle dynamics,
flow cytometric analysis was performed. Figure 2A and B
showed that saffron induced a transient S phase arrest at
6 h in both cell lines and there were p53-dependent effects
on cell cycle phase distribution at later time points.
HCT116 p53 wildtype cells still showed a pronounced
S-phase arrest at 24 h. The HCT116 p53−/− cells, how-
ever, resumed proliferation and released cells into G2/M
phase without showing a remarkable increase in Pre-G1
apoptotic cell fraction. Interestingly, HCT116 p53 wildtype
cells showed a delay in S/G2 checkpoint passage returning
to proliferation later at 48 h. That was clearly shown by a
significant decrease (p<0.05) in S phase and an increase in
G2 phase. In contrast to HCT116 p53 −/− cells 17.4% of
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Figure 1 Anti-proliferative and cytotoxic effects of saffron in HCT116 p53 wildtype and HCT116 p53 −/− cells. MTT viability test showing
the HCT116 p53 wildtype and HCT116 p53 −/− cells untreated (ctrl) or treated with different concentrations of saffron (0.25 to 4.0 mg/ml) for
24 and 48 h (A and B). The MTT data shown are performed in triplicates. Cell numbers were measured using the crystal violet technique after
saffron treatment for 24 and 48 h (C and D). Results are means ± s.d. (n = 3). (*, Saffron treatment was statistically significant against the control for
P < 0.05). (#, Saffron treatment was statistically significant in HCT116 p53 wildtype against HCT116 p53 −/− cells for P < 0.05).
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double S-phase peak in both cell lines but was more obvi-
ous in HCT116 p53 wildtype cells (Figure 2A and B).
Through analyzing two key regulators of G2/M arrest,
namely cyclin B1 and phospho-Histone 3 (pH3), we con-
firmed the FACS analysis. Western blot analysis showed
that there was an early 2-fold up-regulation of cyclin B1
in HCT116 p53 wildtype cells followed by a decrease to
the control level at 24 h. Also the cyclin B1 protein has
nearly completely disappeared at 48 h after saffron treat-
ment (Figure 2C). As expected, this decrease was asso-
ciated with a down regulation of mitosis-specific pH3
suggesting no M phase transition (Figure 2C).
On the other hand, HCT116 p53−/− cells showed a
continuous increase in cyclin B1 protein levels with timeand finally failed to decrease the levels of cyclin B1 and
pH3 at 48 h. This suggests that saffron treatment causes
HCT116 p53 −/− cells to enter mitosis and undergo cell
death possibly at later time points (Figure 2C).
Saffron induces p53-dependent caspase 3 activation in
HCT116 cells
Next we confirmed apoptosis induction in the two
HCT116 p53 isogenic cell lines using the Annexin-PI
staining. We showed a similar time-dependent increase
in the number of apoptotic cells after saffron treatment
in both cell lines compared to the basal apoptosis levels
(Figure 3A and B). However, the early apoptotic fraction
(Annexin-positive and PI-negative) was significantly
higher in HCT116 wildtype cells (p < 0.05) at 48 h (12.8%
HCT wildtype
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Figure 2 Saffron induced cell cycle arrest in HCT116 cells. (A) Two cell types, HCT116 p53 wildtype and HCT116 p53 −/− cells, untreated
(Ctrl) or treated with 3 mg/ml saffron for 24 and 48 h, were harvested and DNA was stained with PI for flow cytometric analysis of DNA content
with FACScan flow cytometry. (B) Quantitative analysis of percentage gated cells at PreG1, G1, S and G2 phases in the HCT116 p53 wildtype
and HCT116 p53 −/− cells. Results are means ± s.d. (n = 3). (C) Western Blot analysis for Cyclin B1, Histone 3, and phosphoHistone 3 (pH3)
expressions in HCT116 p53 wildtype and HCT116 p53 −/− cells, untreated (Ctrl) or treated with 3 mg/ml saffron for 6, 24, and 48 h.
(*, Saffron treatment was statistically significant against the control for P < 0.05).




Ctrl 24h Saffron 48h Saffron













Figure 3 Pro-apoptotic effects of saffron. (A) Annexin-PI measurements of untreated cells (Ctrl) and the two cell types, HCT116 p53 wildtype
and HCT116 p53 −/− cells, treated with 3 mg/ml saffron for 24 and 48 h. The profile represents Annexin-V-FITC staining in x axis and PI in
y axis. (B) Quantitative analysis of percentage gated for viable, necrotic, early apoptotic, and late apoptotic HCT116 p53 wildtype and HCT116
p53 −/− cells treated with 3 mg/ml saffron for 24 and 48 h. Results are means ± s.d. (n = 3). (*, Saffron treatment was statistically significant in
HCT116 p53 wildtype against HCT116 p53 −/− cells for P < 0.05).
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tion, we indicated a higher increase of the cleaved caspase
3 products in HCT116 p53 wildtype cells. This was ac-
companied by an increase in cleavage of its target PARP
(Figure 4A) showing more apoptosis and suggesting that
this saffron-induced DNA-damage is mediated through
the gate keeper p53. Indeed, there was an up-regulation
of p53 protein reaching 4.6-fold values at 48 h. In parallel,
there was a remarkable up-regulation in DNA damage
after saffron treatment as reflected by an increase in pro-
tein levels of γH2AX, a sensor of DNA double strand
breaks (Figure 4B). But HCT116 p53 −/− cells showed an
increase in γH2AX already after 24 h and the levelswhere approximately 2.5-fold higher compared to the
HCT116 p53 wildtype cells at 48 h (Figure 4B).
Saffron induces a massive autophagic cell death in
HCT116 p53 −/− cells
We next ask the question, what is protecting HCT116
p53 −/− cells from apoptosis after the observed severe
DNA damage. In order to address this, we investigated
whether saffron induces hallmarks of autophagy in a
p53-dependent manner. The level of LC3-II, a protein
that accumulates as a result of increased autophagosome
formation [24], was assessed. Indeed, saffron induced a
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Figure 4 Saffron induced DNA damage and autophagy. (A) Western Blot analysis for caspase 3 and PARP cleavage in two cell types,
HCT116 p53wildtype and HCT116 p53 −/− cells, untreated (Ctrl) or treated with 3 mg/ml saffron for 6, 24, and 48 h. (B) Western Blot analysis for
γH2AX expression in HCT116 p53 wildtype and HCT116 p53 −/− cells, untreated (Ctrl) or treated with 3 mg/ml saffron for 6, 24, and 48 h.
(C) Western Blot analysis for LC3 expression in HCT116 p53 wildtype and HCT116 p53 −/− cells, untreated (Ctrl) or treated with 3 mg/ml saffron
for 6, 24, and 48 h. (D) Western Blot analysis for Beclin 1 expression in HCT116 p53 wildtype and HCT116 p53 −/− cells, untreated (Ctrl) or
treated with 3 mg/ml saffron for 6, 24, and 48 h.
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cells after 24 h and 48 h, (Figure 4B), although there was
a higher basal rate of autophagy in HCT116 p53−/−
cells. Studying Beclin 1, which is known to interfere with
autophagic vesicle formation, allowed us to find a higher
beclin 1 protein levels in the HCT116 p53 −/− cells after
saffron treatment. We, therefore, suggest that autophagic
disposal of damaged cell debris might reduce or delay
the cell death induction after saffron treatment in
HCT116 p53 −/− cells.
Discussion
Natural products have long been used to prevent and treat
diseases including cancers and might be good candidates
for the development of anti-cancer drugs [25]. Saffron, a
commonly-used spice and food additive, is known for its
anti-cancer and anti-tumor properties [12-16].
Because most of the in vivo studies were interested in
the isolated bioactive compounds of saffron, little re-
search has been done to examine anti-cancer properties
of saffron in its natural form. Tavakkol-Afshari and col-
leagues [26] reported that 96% ethanol saffron extract is
selectively cytotoxic against epithelial-like human hepa-
tocellular carcinoma cells (HepG-2) as well as human
cervical carcinoma cells (HeLa) but nontoxic towards
normal mouse fibroblast cells (L929). The additive and
synergistic effects among the different phytochemicals insaffron however, may enhance its anti-carcinogenic
properties [27]. Based on those reports, more studies are
necessary to determine the beneficial effects of saffron in
its natural form using human subjects [9].
In this study, we analyzed the possible role of p53 in
the cytotoxic, anti-proliferative and pro-apoptotic effects
of saffron on two p53 isogenic HCT116 cell lines. Cell
proliferation inhibition test using MTT viability assay as
well as crystal violet staining confirmed that ethanolic
extract of saffron has cytotoxic activity against HCT116
cells. The present results were in agreement with previ-
ous reports indicating that saffron and its ingredients
possessed anti-tumor and anti-cancerogenic activities
and have no cytotoxic effect on non-malignant cells
[9,26,27]. Consistent with our previous study on HepG-2
cells [11], saffron extract induced a significant toxicity in
HCT116 after 48 h. Similarly, HCT116 cells were shown
to have a significant higher sensitivity to saffron extract
compared to other colorectal cancer cell lines; SW-480
and HT-29 [27]. The observed apoptotic induction in
HCT116 p53 wildtype cells obviously resulted from
DNA damage as reflected by the up-regulation of the
double-stranded DNA breakage marker, γH2AX, sug-
gesting an additional role of saffron in sensitizing cancer
cells to the effects of other chemotherapeutics.
In cancer chemotherapy, cancer programmed cell
death has been emphasized and shown to be mediated
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apoptosis, cell cycle regulation and DNA repair in re-
sponse to a wide range of cellular stresses. Mutations in
p53 have been found in almost 50% of all colorectal can-
cers worldwide [28] and at high frequencies in many dif-
ferent cancers [2]. We investigated whether saffron
treatment induced p53-dependent cell cycle arrest,
apoptosis or autophagy in HCT116 cell lines. Sluggish
S-phase transit was a remarkable effect of saffron in
both cell lines. To better understand the subsequent G2/
M arrest, we studied the Cyclin B1 protein levels be-
cause a proper Cyclin B1 regulation is known to be ne-
cessary for the entry into mitosis [29]. The low Cyclin
B1 and pH3 levels in HCT116 p53 wildtype cells reflect
that saffron induces a full G2 arrest after 48 h of treat-
ment without allowing the cells to enter the M phase.
Cells without p53 but high Cyclin B1 and pH3 levels
clearly enter the M phase and further accumulate severe
saffron-induced DNA damage as reflected by the in-
crease in pH2AX protein levels.
The role of p53 in autophagy, programmed cell
death form II, remains controversial with studies sug-
gesting presence of p53, as well as absence of p53, as
inducer of autophagy [30]. In the present study, both
cell lines showed accumulation of autophagosomes
after saffron treatment monitored by the increase in
the lipidated LC3-II protein. There are two forms of
LC3 proteins: the cytoplasmic LC3-I and the autopha-
gosome membrane-bound LC3-II form. The failure
in repairing the massively damaged DNA by a lack
in p53 led to a significant higher LC3-II proportion after
saffron treatment. This effect has been observed also
after prolonged starvation [31] and has been interpreted
as an increased functional autophagy in p53 −/− cells.
In the absence of p53, autophagosome recycling is pos-
sibly less effective and the observed increase in LC3-II
forms after saffron treatment of HCT116 p53 −/− cells
could also reflect the aberrant accumulation of static
autophagosomes. This would slow down the autophagic
flux, cause accumulation of aberrant protein intermedi-
ates and would have a later effect on apoptosis. Thus
autophagy would ultimately lead to a delay in apoptosis
and protection of cells from cell death. The time inter-
val observed in our study suggests a rather pro-survival
role of saffron-induced autophagy. Indeed, the role of
autophagy in cancer development is complex, as it has
been implicated in both tumor survival and tumor cell
death [32,33]. At the present time, we still do not know
the genes responsible for inducing autophagy in the
p53 −/− cells after saffron treatment. We could how-
ever speculate that a p53 homolog such as p73 may
have been activated in p53−/− cells and modulated
autophagy [34] or mild apoptosis. In this regard, it has
been shown that p73 interacts with p53-responsiveelements and induces transcription of p53-inducible
genes [35].
Despite the accumulating evidence demonstrating
that saffron may be a promising cancer therapy agent,
mechanisms of saffron anti-cancer actions are still
largely unknown. Many proposed mechanisms have
been reported. Bathaie and colleagues [36] found that
saffron carotenoids directly bind to DNA minor
grooves and induce conformational changes of tar-
geted DNA. The induction of apoptosis by saffron has
been reported to play an essential role in the death of
human hepatocellular carcinoma cells and HeLa cells
[11,26]. Although saffron demonstrates potential as an
anti-cancer drug, further research is needed to eluci-
date the mechanisms and effects of saffron in p53 −/−
tumors. The therapeutic endpoint in p53 −/− tumor
cells has to be clarified using long term assays and in vivo
models.
Conclusion
In conclusion, data from this study suggests that saffron
shows a p53-dependent efficacy in colorectal cancer.
There seems to be a pro-survival role of autophagy in
saffron-induced damage response in p53 −/− tumors.
Considering the popularity of herbal use in cancer
patients, saffron and especially its active ingredients
should be investigated further as a viable option in the
treatment of colorectal cancer.
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